UK markets closed

Myriad Genetics, Inc. (0K3W.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
23.30+1.31 (+5.98%)
At close: 02:44PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.96
52-week change 3-7.62%
S&P500 52-week change 323.76%
52-week high 324.13
52-week low 30.00
50-day moving average 320.63
200-day moving average 320.78

Share statistics

Avg vol (3-month) 3237
Avg vol (10-day) 3238
Shares outstanding 574.76M
Implied shares outstanding 6N/A
Float 871.3M
% held by insiders 12.18%
% held by institutions 1105.85%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -30.30%
Operating margin (ttm)-13.80%

Management effectiveness

Return on assets (ttm)-6.60%
Return on equity (ttm)-29.41%

Income statement

Revenue (ttm)774.2M
Revenue per share (ttm)9.11
Quarterly revenue growth (yoy)11.60%
Gross profit (ttm)N/A
EBITDA -67.8M
Net income avi to common (ttm)-234.6M
Diluted EPS (ttm)-0.11
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)104.3M
Total cash per share (mrq)1.15
Total debt (mrq)146.8M
Total debt/equity (mrq)19.32%
Current ratio (mrq)1.99
Book value per share (mrq)8.40

Cash flow statement

Operating cash flow (ttm)-96.3M
Levered free cash flow (ttm)-36.7M